Srijanee Das

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Antiretroviral Therapy

Hepatitis B Virus

Top Venues

Science advances

Communications biology

FEMS microbiology reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Farhana Islam, Srijanee Das, Md Ashaduzzaman, Brady Sillman, Pravin Yeapuri, Mohammad Ullah Nayan, Minjie Sun, Howard E Gendelman, Bhavesh D Kevadiya
Development of an extended action fostemsavir lipid nanoparticle. Communications biology 7 (1) (2024)
Farhana Islam, Srijanee Das, Md Ashaduzzaman, Brady Sillman, Pravin Yeapuri, Mohammad Ullah Nayan, Minjie Sun, Howard E Gendelman, Bhavesh D Kevadiya
Development of an extended action fostemsavir lipid nanoparticle. Communications biology 7 (1) (2024)
Farhana Islam, Srijanee Das, Md Ashaduzzaman, Brady Sillman, Pravin Yeapuri, Mohammad Ullah Nayan, Minjie Sun, Howard E Gendelman, Bhavesh D Kevadiya
Development of an extended action fostemsavir lipid nanoparticle. Communications biology 7 (1) (2024)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Milankumar Patel, Farah Shahjin, Jacob D Cohen, Mahmudul Hasan, Jatin Machhi, Heerak Chugh, Snigdha Singh, Srijanee Das, Tanmay A Kulkarni, Jonathan Herskovitz, Douglas D Meigs, Ramesh Chandra, Kenneth S Hettie, R Lee Mosley, Bhavesh D Kevadiya, Howard E Gendelman
The Immunopathobiology of SARS-CoV-2 Infection. FEMS microbiology reviews 45 (6) (2021)